Mark Wener to Risk Factors
This is a "connection" page, showing publications Mark Wener has written about Risk Factors.
Connection Strength
0.012
-
Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Jun 03; 21(1):475.
Score: 0.007
-
Low HDL-cholesterol among HIV-1 infected and HIV-1 uninfected individuals in Nairobi, Kenya. Lipids Health Dis. 2017 Jun 09; 16(1):110.
Score: 0.005